FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

9796511000001100: Cicafem 2000/35 tablets (koGEN Limited) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
31684101000001115 Cicafem 2000/35 tablets (koGEN Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
42895601000001115 Cicafem 2000/35 tablets (Galen Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cicafem 2000/35 tablets (koGEN Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has excipient Lactose false Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Is a Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has active ingredient Cyproterone acetate false Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has active ingredient Estradiol false Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Is a Cicafem true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has specific active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cicafem 2000/35 tablets (koGEN Limited) 63 tablet 3 x 21 tablets Is pack of False Cicafem 2000/35 tablets (koGEN Limited) Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) 63 tablet 3 x 21 tablets Has AMP True Cicafem 2000/35 tablets (koGEN Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start